NCT05211804View on ClinicalTrials.gov

Mechanisms of Retinal Revascularization and Clinical Indicators of Neovascular AMD Relapse

CompletedOBSERVATIONAL

Enrollment

31

Participants

Timeline

Start Date

February 8, 2022

Primary Completion Date

May 21, 2024

Study Completion Date

May 21, 2024

Conditions

Wet Macular Degeneration

Interventions

DRUG

Ophthalmic Drugs

Patients will receive the same treatment as if not a part of the project

Trial Locations (1)

4838

Sorlandet Hospital HF, Arendal

All Listed Sponsors

lead

Sorlandet Hospital HF

OTHER_GOV